Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
101M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
64.1K
-
Shares change
-
-31.4K
-
Total reported value, excl. options
-
$1.79M
-
Value change
-
-$752K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$27.22
Significant Holders of Beam Therapeutics Inc. - Common Stock (BEAM) as of Q4 2023
4 filings reported holding BEAM - Beam Therapeutics Inc. - Common Stock as of Q4 2023.
Beam Therapeutics Inc. - Common Stock (BEAM) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.1K shares
of 101M outstanding shares and own 0.06% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (9.39M shares), VANGUARD GROUP INC (7.16M shares), BlackRock Inc. (6.66M shares), FMR LLC (6.18M shares), STATE STREET CORP (4.62M shares), MORGAN STANLEY (4.18M shares), FARALLON CAPITAL MANAGEMENT LLC (4.11M shares), Temasek Holdings (Private) Ltd (3.08M shares), Nikko Asset Management Americas, Inc. (2.36M shares), and Sumitomo Mitsui Trust Holdings, Inc. (2.36M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.